PAX9 and lung cancer: Gain at 14q13 has been studied in relation to lung cancer [37], and co-amplification and overexpression of the transcription factors TTF-1, NKX2-8, and PAX9 (all located at 14q13) have been associated with cisplatin resistance in lung cancer cell lines [38].